Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PL1I
|
|||
| Drug Name |
US9359293, TA
|
|||
| Synonyms |
SCHEMBL18103200; CHEMBL3892393; BDBM234205; US9359293, TA
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H25N3O3S
|
|||
| Canonical SMILES |
CC(=S)NCCCCC(C(=O)NC1=CC=CC=C1)NC(=O)OC2=CC=CC=C2
|
|||
| InChI |
1S/C21H25N3O3S/c1-16(28)22-15-9-8-14-19(20(25)23-17-10-4-2-5-11-17)24-21(26)27-18-12-6-3-7-13-18/h2-7,10-13,19H,8-9,14-15H2,1H3,(H,22,28)(H,23,25)(H,24,26)
|
|||
| InChIKey |
KPDAUKDFHIWNQM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target's Patent Info | [1] | |
| Pathway Interaction Database | Signaling events mediated by HDAC Class III | |||
| Signaling events mediated by HDAC Class I | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Methods of treatment using modulators of SIRT2. US9359293. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.